Lupin partners with Takeda to launch novel gastrointestinal drug Vonoprazan in India
In a significant development, Lupin Limited, a global pharmaceutical leader, announced a non-exclusive patent licence agreement with Takeda Pharmaceutical Company Limited to commercialise Vonoprazan Tablets in the Indian market. The medication, set to be marketed under Lupin’s brand name Lupivon, will be available in two strengths—10 mg and 20 mg—bringing a novel gastrointestinal drug to […]